TY - JOUR
T1 - The Role of Noninvasive Imaging in Coronary Artery Disease Detection, Prognosis, and Clinical Decision Making
AU - Dowsley, Taylor
AU - Al-Mallah, Mouaz
AU - Ananthasubramaniam, Karthik
AU - Dwivedi, Girish
AU - McArdle, Brian
AU - Chow, Benjamin J.W.
N1 - Funding Information:
Benjamin Chow is the principle investigator of Ima ging to G uide E valuation of H eart F ailure (IMAGE HF)-project IC (Canadian Institutes for Health Research [CIHR] team grant [CIF 99470]), which has helped to support this work. Benjamin Chow is also supported by CIHR New Investigator Award MSH-83718. This study was supported in part by the Ontario Research Fund: Imaging for Cardiovascular Therapeutics.
Funding Information:
Benjamin Chow receives research support from GE Healthcare, Pfizer, and AstraZeneca, fellowship support from GE Healthcare, and educational support from TeraRecon Inc. The remaining authors have no conflicts of interest to disclose.
Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/3
Y1 - 2013/3
N2 - A vast array of noninvasive imaging modalities is available for the evaluation of the presence and severity of coronary artery disease (CAD). Choosing the right test can be challenging but is critical for proper patient diagnosis and management. Presently available imaging tests for CAD include: (1) nuclear myocardial perfusion imaging procedures (single-photon emission tomography) and positron emission tomography, (2) stress echocardiography, (3) computed tomography coronary angiography, and (4) cardiac magnetic resonance imaging. Exercise treadmill testing electrocardiography is another alternative that we will discuss briefly. Selection of the most appropriate imaging modality requires knowledge of the clinical question being addressed, patient characteristics (pretest probability and prevalence of disease), the strengths, limitations, risks, costs, and availability of each procedure. To assist with test selection, we review the relevant literature in detail to consider the relative merits of cardiac imaging modalities for: (1) detection of CAD, (2) risk stratification and prognostication, and (3) guiding clinical decision making.
AB - A vast array of noninvasive imaging modalities is available for the evaluation of the presence and severity of coronary artery disease (CAD). Choosing the right test can be challenging but is critical for proper patient diagnosis and management. Presently available imaging tests for CAD include: (1) nuclear myocardial perfusion imaging procedures (single-photon emission tomography) and positron emission tomography, (2) stress echocardiography, (3) computed tomography coronary angiography, and (4) cardiac magnetic resonance imaging. Exercise treadmill testing electrocardiography is another alternative that we will discuss briefly. Selection of the most appropriate imaging modality requires knowledge of the clinical question being addressed, patient characteristics (pretest probability and prevalence of disease), the strengths, limitations, risks, costs, and availability of each procedure. To assist with test selection, we review the relevant literature in detail to consider the relative merits of cardiac imaging modalities for: (1) detection of CAD, (2) risk stratification and prognostication, and (3) guiding clinical decision making.
UR - http://www.scopus.com/inward/record.url?scp=84874327687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874327687&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2012.10.022
DO - 10.1016/j.cjca.2012.10.022
M3 - Review article
C2 - 23357601
AN - SCOPUS:84874327687
VL - 29
SP - 285
EP - 296
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
SN - 0828-282X
IS - 3
ER -